Provider of laboratory and research services. The company's services include laboratory research and testing for Lyme and associated tick-borne diseases in a comprehensive way to test relevant strains of tick-borne pathogens including those pathogens that exhibit Lyme-like symptoms but may be due to a different tick-borne disease and require different treatment paths, enabling patients to make a timely diagnosis of Lyme diseases for starting the right treatment.
Year Founded
1991
Employees
2
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Privately Held (backing)
-
Financing Status
Private Equity-Backed
IGeneX News and Updates
Lyme Disease Diagnostics Market Estimated to Expand at a Robust CAGR by 2031
Digital Journal | July 4, 2022
“How treating Bartonella cleared most of my son's symptoms of autism”
St. Louis Jewish Light | June 29, 2022
IGeneX and Kelley Flanagan Tackle Tick-Borne Disease as Cases Climb by 59% in the United States
PR Newswire | June 8, 2022
‘I’m an Epidemiologist, and Here’s What You Need To Know About Subvariants and Variants’
Well+Good | June 1, 2022
‘I’m an Epidemiologist, and This Is What It Means When COVID Cases Are Up—But Deaths Remain Low’
Well+Good | May 26, 2022
Doctors debate, patients suffer: The fight over chronic Lyme disease in Wisconsin
Wisconsin Public Radio | March 13, 2022